SWEDISH GOVERNMENT HOLDS DECISION ON NORRA KÄRR EXPLOITATION CONCESSION; DIRECTORS EXERCISE OPTIONS INJECTING NEW CAPITAL; INVESTOR RELATIONS ENGAGEMENT Every government…
ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), is approved for use in Australia and Singapore as a first-line maintenance treatment for…